How Cells Die Determines Whether Immune System Mounts Response

An RPB vision researcher's finding could have important implications in the treatment of autoimmune diseases and cancer.   Thomas A. Ferguson, Ph.D., Washington University School of Medicine, received an RPB Lew R. Wasserman... Read more...

 

New Vision Screening Device Provides Early Warning of Diabetic Eye Disease

  Watch a video of Dr. Elner explaining the significance of this development for the early detection of diabetes and diabetes-related eye... Read more...

 

Gene Therapy Proven Effective for Patients with Inherited Retinal Disease

Researchers have used gene therapy to safely restore vision in three young adults with a form of retinitis pigmentosa known as Leber's congenital amaurosis (LCA), an inherited retinal disorder that reduces vision in early childhood and... Read more...

 

RPB-Supported Scientist Revolutionizes Gene Research

A dramatic new study, supported by Research to Prevent Blindness, questions some of the mechanisms underlying a new class of drugs based on Nobel Prize-winning work designed to fight diseases ranging from macular degeneration to... Read more...

 

Macular Degeneration, Diabetic Retinopathy Reversed

Two leading causes of blindness can be reversed or even prevented by drugs that activate a protein found in blood vessel cells. The discovery is an example of basic science research yielding a discovery with direct clinical applications. Read more...

 

New Hope for Regenerating the Human Retina

In a radical breakthrough, RPB scientists have demonstrated the possibility of chemically signaling the eye's own resources to regenerate retina cells, without transplanting retinal tissue or stem cells.        ... Read more...

 

RPB Supports Development of Device for Early Warning of Eye Disease

Ann Arbor, MI – Scientists at the University of Michigan have shown that their new metabolic imaging instrument can accurately detect eye disease at a very early stage. Such a device would be vision-saving because many severe eye... Read more...

 

RPB Gave $10.94 Million In Grants In 2007

New York, NY, January 11, 2008 -- Research to Prevent Blindness (RPB), the leading voluntary health organization supporting eye research, awarded 93 grants totaling $10.94 million in 2007.  Departments of ophthalmology at 56 medical... Read more...

 

RPB Supports World Glaucoma Day

As a major contributor to the comprehensive effort to treat, prevent and cure glaucoma, Research to Prevent Blindness is joining with institutions and organizations worldwide to raise awareness about the need to be tested for glaucoma if... Read more...

 

Immune Cell Clues To Age-Related Macular Degeneration

An RPB researcher has found that the age of immune cells, called macrophages, may be key in determining whether damaging blood vessels will form beneath the retina and contribute to vision loss in age-related macular degeneration.  A... Read more...

 

 

More News From RPB

RPB Supports Breakthrough Finding In Eye Development, Eye Cancer

Research Uncovers Insufficient Vision Care for Elderly In Nursing Homes

How Research to Prevent Blindness Worked To Advance Ophthalmology

RPB Researcher Identifies Eye Cancer Cell

Artificial Cornea: New Option for the Treatment of Corneal Conditions

RPB Chairman David F. Weeks Receives ARVO Award

Researcher Receives RPB Award for Innovative Technology